According to an innovative, pioneering model put in place by founder, S. B. Ranger, Seagreens business is highly distributed. Production is no exception, with a number of different third parties each playing a vital role in the total process.
The whole comprises what is known as Seagreens® International Partnership®. Seagreens Partners are responsible for most aspects of harvesting, processing, distribution, sales, marketing and new product development. Central operations focus on the management of this unique international partnership and developing the Seagreens brand.
Seagreens® ingredients for food and nutrition product manufacturing are harvested and processed by Seagreens Partners in registered food facilities with full adoption of internationally-recognised Good Manufacturing Practice (GMP), Good Hygiene Practice (GHP), Hazard Analysis Critical Control Point (HACCP) procedures, with all final processing and production certified to British Retail Consortium (BRC) Global Standard for Food Safety (Issue 7).
Seagreens finished products for healthcare practitioners and consumers are produced in certified facilities approved to BRC, MHRA, ISO 9001, and FDA quality and safety standards. Relevant production sites have EU Organic and Marine Sustainability accreditation.
Our encapsulated products for everyday dietary and therapeutic use, are manufactired by our long standing Partner G & G Food Supplies, one of Europe’s leading nutrition product manufacturers, a member of the Institute of Quality Assurance and the UK Health Food Manufacturers’ Association. This short G & G video explains the encapsulation process.
Seagreens® nutrition and natural remedy products are encapsulated in a Pharmaceutical Clean Room complex validated ISO Class 9 in accordance with ISO 14644-1(1999).
Encapsulation in rapidly soluble hypromellose capsules of 100% vegetable origin* employs a proprietary filling method (Trufil®) which exceeds industry standard average content practice, ensuring the minimum content stated on the jar, rathe than the 'average' content used in conventional filling.
Independent analysis of all ingredients conforms with British FSA and US FDA regulations; reserve samples are kept for investigation 12 months from batch production date.
*GRAS-listed HPMC: United States and European Pharmacopoeias, ref. EP1997/USP24, EU no. E464